BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35226292)

  • 1. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.
    Musunuri B; Shetty S; Bhat G; Udupa K; Pai A
    Indian J Gastroenterol; 2022 Apr; 41(2):127-134. PubMed ID: 35226292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.
    Sood A; Midha V; Goyal O; Goyal P; Sood N; Sharma SK
    Indian J Gastroenterol; 2014 Jan; 33(1):35-40. PubMed ID: 24222369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
    Prabhakar T; Kaushal K; Prasad M; Gupta E; Sood A; Jain AK; Shukla A; Goel A; Duseja A; Saraya A; Shah S; Kumar G; Sarin SK
    Hepatol Int; 2023 Jun; 17(3):745-752. PubMed ID: 36940070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
    Tovo CV; de Mattos AZ; Coral GP; Sartori GDP; Nogueira LV; Both GT; Villela-Nogueira CA; de Mattos AA
    World J Gastroenterol; 2023 Jan; 29(2):343-356. PubMed ID: 36687125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD.
    Kim GA; Park Y; Oh SJ; Jung J; Han S; Chang HS; Park SW; Kim TH; Park HW; Choe J; Kim J; Lee HC
    Liver Int; 2024 Mar; 44(3):738-748. PubMed ID: 38110797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System.
    Kikuchi L; Oliveira CP; Alvares-da-Silva MR; Tani CM; Diniz MA; Stefano JT; Chagas AL; Alencar RS; Vezozzo DC; Santos GR; Campos PB; Alves VA; Ratziu V; Carrilho FJ
    Am J Clin Oncol; 2016 Oct; 39(5):428-32. PubMed ID: 25268068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
    Meringer H; Shibolet O; Deutsch L
    World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
    Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
    Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.
    Polyzos SA; Chrysavgis L; Vachliotis ID; Chartampilas E; Cholongitas E
    Semin Cancer Biol; 2023 Aug; 93():20-35. PubMed ID: 37149203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population.
    Šafčák D; Dražilová S; Gazda J; Andrašina I; Adamcová-Selčanová S; Barila R; Mego M; Rác M; Skladaný Ľ; Žigrai M; Janičko M; Jarčuška P
    Curr Oncol; 2023 Mar; 30(3):3557-3570. PubMed ID: 36975484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India.
    Paul SB; Sreenivas V; Gulati MS; Madan K; Gupta AK; Mukhopadhyay S; Panda SK; Acharya SK
    Indian J Gastroenterol; 2007; 26(6):274-8. PubMed ID: 18431010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Li B; Cheung KS; Yuen MF; Seto WK
    Hepatol Int; 2021 Aug; 15(4):901-911. PubMed ID: 34152534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Pinyopornpanish K; Al-Yaman W; Dasarathy S; Romero-Marrero C; McCullough A
    Dig Dis Sci; 2022 Jun; 67(6):2677-2687. PubMed ID: 34027591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
    Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.